Hamidreza Ghanbari

Dr. Hamidreza Ghanbari

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2024 in Microvascular Research
Verified
Journal Article
Closed access
AMAhmad Masoumi
Ahmad Masoumi
AEAmirreza Esfandiari
Amirreza Esfandiari
AKAtefeh Khalili
Atefeh Khalili
GLGolshan Latifi
Golshan Latifi
HGHamidreza Ghanbari
Hamidreza Ghanbari
SGSadegh Ghafarian
Sadegh Ghafarian

6 April 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
HGHamidreza Ghanbari
Hamidreza Ghanbari
NBNikoo Bayan
Nikoo Bayan
SRShakiba Rahimi
Shakiba Rahimi
FSFarhad Salari
Farhad Salari
MDMohammadreza Toghyani DolatAbadi
Mohammadreza Toghyani DolatAbadi
MSMohammad Soleimani
Mohammad Soleimani
Ocular surface tumors (OSTs) are rare but potentially life-threatening neoplasms encompassing entities such as ocular surface squamous neoplasia (OSSN), conjunctival melanoma, and lymphoma. Accurate diagnosis often requires expert ophthalmologists and pathologists, compounded by the reliance on advanced imaging modalities, with excisional biopsy being the gold standard. These limitations underscore the need for less invasive, accessible diagnostic approaches, where artificial intelligence (AI) holds significant promise. This review provides a comprehensive overview of AI advancements in OST management. It begins with definitions of AI and its key branches, followed by an examination of AI models applied to ophthalmic tumors using imaging data. Current developments in AI-related diagnostic tools for OSTs are discussed, highlighting their potential to enhance patient management, with classifications based on imaging modalities and specific OST types. Finally, the review addresses main challenges in AI implementation, including data limitations and ethical considerations, while outlining future directions to integrate AI into clinical ophthalmology practice. By bridging technological innovation with clinical needs, AI shows promise in OST diagnosis and management, ultimately improving outcomes in this challenging condition.

28 August 2025 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
MAMehrnaz Atighehchian
Mehrnaz Atighehchian
FAFateme Alipour
Fateme Alipour
HGHamidreza Ghanbari
Hamidreza Ghanbari
PAParya Abdolalizadeh
Parya Abdolalizadeh
HHHesam Hashemian
Hesam Hashemian